menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Impax Inks $145M Deal With Direct Purchasers In Opana MDL

    LAW360

    Families impacted by the opioid epidemic closely watching J&J trial

    CBSNEWS

    FDA declines to approve Mallinckrodt`s abuse-deterrent opioid painkiller

    REUTERS

    FDA to Replace Analgesic Drug Development Guidance With New Documents

    RAPS

    FDA declines to approve Pain Therapeutics` opioid drug, shares plunge

    REUTERS

    Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis

    FIERCE PHARMA

    Ascent Pharm’s Generics Oxymorphone Hydrochloride Receives Approval In US

    FDA

    U.S. subpoenas Endo for information on opioid painkillers

    REUTERS

    Spoiler alert: IBD superheroes prevail as Takeda wraps its Marvel Comics project

    FIERCE PHARMA

    News of Note—GlaxoSmithKline’s R&D fix; Leo-HitGen deal; Stanford I-O pact

    FIERCE BIOTECH

    Impax Announces Settlement of Contract Litigation on Opana® ER Oxymorphone HCL

    PR NEWSWIRE

    Report Calls on FDA to Adopt New Standard for Reviewing Opioids

    RAPS

    Endo Pulls Opioid From US Market at FDA`s Request

    RAPS

    FDA Asks Drug Company to Pull its Opioid Opana Because of Abuse

    NBC NEWS

    Endo`s (ENDP) Opana ER`s Risk Benefit Evaluated by FDA

    NASDAQ

    FDA Panel To Re-Examine Opana ER

    SEEKING ALPHA

    Is Kratom a Deadly Drug or a Life-Saving Medicine?

    BLOOMBERG

    Endo withdraws bid to add `abuse deterrent` to Opana`s label

    FIERCE PHARMA

    Aurobindo Pharma gets US Food and Drug Administration nod for two drugs

    ECONOMIC TIMES

    KemPharm plans to develop prodrug of oxymorphone

    BIOSPECTRUM ASIA

    Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property

    PR NEWS WIRE

    Endo`s Opana ER (Oxymorphone Hcl) Receives Supplemental Approval in US For Pain

    FDA

    Abandoned Painkiller Makes a Comeback

    MEDPAGE TODAY

    Collegium swings for a $75M IPO for its abuse-proof painkiller

    FIERCE BIOTECH

    Sun`s Generic Oxymorphone Hcl Approved in USA For Moderate to Severe Pain

    FDA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.